Effectiveness of “catch-up” human papillomavirus vaccination on incident cervical neoplasia in a U.S. healthcare setting

BACKGROUND. Limited data exist regarding population effectiveness of human papillomavirus (HPV) catch-up vaccination, defined in the United States as first vaccination at ages 13–26 years. We evaluated the risk of cervical intraepithelial neoplasia 2, 3, adenocarcinoma in situ or cancer (CIN2+ and C...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Lancet Child Adolesc Health
Päätekijät: Silverberg, Michael J., Leyden, Wendy A., Lam, Jennifer O., Gregorich, Steven E., Huchko, Megan J., Kulasingam, Shalini, Kuppermann, Miriam, Smith-McCune, Karen K., Sawaya, George F.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2018
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6152835/
https://ncbi.nlm.nih.gov/pubmed/30236379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2352-4642(18)30220-7
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia